[1]
2019. DIFFERENCES IN EX-VIVO CHEMOSENSITIVITY TO ANTHRACYCLINES IN FIRST LINE ACUTE MYELOID LEUKEMIA. Mediterranean Journal of Hematology and Infectious Diseases. 11, 1 (Feb. 2019), e2019016. DOI:https://doi.org/10.4084/mjhid.2019.016.